Molecular modelling and 1H-NMR:: Ultimate tools for the investigation of tolbutamide : β-cyclodextrin and tolbutamide : hydroxypropyl-β-cyclodextrin complexes

被引:58
作者
Veiga, FJB [1 ]
Fernandes, CM
Carvalho, RA
Geraldes, CFGC
机构
[1] Univ Coimbra, Fac Pharm, Lab Pharmceut Technol, Coimbra, Portugal
[2] Univ Coimbra, Dept Biochem, Coimbra, Portugal
关键词
tolbutamide; cyclodextrin; H-1-NMR; molecular modelling;
D O I
10.1248/cpb.49.1251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A structural study of the inclusion compound of tolbutamide (TBM) with beta -cyclodextrin (beta -CD) and hydroxypropyl-beta -cyclodextrin (HP-beta -CD) was attempted by means of H-1-nuclear magnetic resonance (H-1-NMR) experiments and computer molecular modelling. To establish the stoichiometry and stability constant of the beta -CD:TBM complex, the continuous variation method was used. The presence of true inclusion complexes between TBM and beta -CD or HP-beta -CD in solution was clearly evidenced by the H-1-NMR technique. Changes in chemical shifts of H-3 and H-5 protons, located inside the CD cavity, associated with variations in the chemical shifts of TBM aromatic protons provided clear evidence of inclusion complexation, suggesting that the phenyl moiety of the drug molecule was included in the hydrophobic cavity of CDs. This view was further supported by the observation of intermolecular NOEs between TBM and beta -CD and by the aid of a molecular modelling program, which established the most probable structure of the complex. The molecular graphic computation confirmed that the minimum energy, positioning TBM relative to beta -CD, occurs when the aromatic ring of TBM is included within the beta -CD cavity by its wider side, leaving the aliphatic chain externally, which is in good agreement with the results of H-1-NMR studies.
引用
收藏
页码:1251 / 1256
页数:6
相关论文
共 33 条
[1]  
Cabrer PR, 1999, LANGMUIR, V15, P5489
[2]   Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin [J].
Dhanaraju, MD ;
Kumaran, KS ;
Baskaran, T ;
Moorthy, MSR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (06) :583-587
[3]   Solubility, 1H-NMR, and molecular mechanics of mebendazole with different cyclodextrins [J].
Díaz, D ;
Bernad, MJB ;
Garcia-Mora, J ;
Llanos, CME .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (01) :111-115
[4]   HIGH-FIELD NUCLEAR-MAGNETIC-RESONANCE TECHNIQUES FOR THE INVESTIGATION OF A BETA-CYCLODEXTRIN-INDOMETHACIN INCLUSION COMPLEX [J].
DJEDAINI, F ;
LIN, SZ ;
PERLY, B ;
WOUESSIDJEWE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :643-646
[5]   NUCLEAR-MAGNETIC-RESONANCE INVESTIGATION OF THE STOICHIOMETRIES IN BETA-CYCLODEXTRIN - STEROID INCLUSION COMPLEXES [J].
DJEDAINI, F ;
PERLY, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (12) :1157-1161
[6]   Binding of cyclodextrins to alicyclic and aromatic substrates: Complex formation of alpha-, beta-, and gamma-cyclodextrins with substituted cyclohexanecarboxylic acids and phenylalkanoic acids [J].
Gadre, A ;
Rudiger, V ;
Schneider, HJ ;
Connors, KA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) :236-243
[7]   A PROTON NUCLEAR-MAGNETIC-RESONANCE STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN [J].
GANZAGONZALEZ, A ;
VILAJATO, JL ;
ANGUIANOIGEA, S ;
OTEROESPINAR, FJ ;
BLANCOMENDEZ, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 106 (03) :179-185
[8]  
Job P, 1928, ANN CHIM FRANCE, V9, P113
[9]   CYCLODEXTRIN COMPLEXATION OF NSAIDS - PHYSICOCHEMICAL CHARACTERISTICS [J].
LOFTSSON, T ;
OLAFSDOTTIR, BJ ;
FRIORIKSDOTTIR, H ;
JONSDOTTIR, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 1 (02) :95-101
[10]   Use of a nonlinear least-squares model for the kinetic determination of the stability constant of cyclodextrin inclusion complexes [J].
Loukas, YL ;
Vraka, V ;
Gregoriadis, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 144 (02) :225-231